Geneos Wealth Management’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$705K Sell
3,650
-1,650
-31% -$204K 0.01% 681
2026
Q2
$545K Sell
5,300
-1,750
-25% -$114K 0.01% 708
2026
Q1
$335K Sell
7,050
-1,900
-21% -$85.2K 0.01% 806
2025
Q4
$284K Buy
8,950
+3,500
+64% +$109K 0.01% 815
2025
Q3
$153K Buy
5,450
+2,800
+106% +$84.8K ﹤0.01% 997
2025
Q2
$97.5K Buy
+2,650
New +$91.6K ﹤0.01% 1267
2022
Q1
– Sell
-2,825
Closed -$218K – 2983
2021
Q4
$218K Sell
2,825
-500
-15% -$51.3K 0.01% 827
2021
Q3
$350K Buy
3,325
+900
+37% +$103K 0.01% 665
2021
Q2
$318K Buy
2,425
+1,800
+288% +$209K 0.01% 673
2021
Q1
$83K Sell
625
-750
-55% -$114K ﹤0.01% 1383
2020
Q4
$159K Buy
+1,375
New +$153K 0.01% 922

Other funds holding TWST

Geneos Wealth Management's TWST Position: Q3 2026 in Review

Geneos Wealth Management reduced its Twist Bioscience (TWST) stake by 31% in Q3 2026, selling an estimated $204K and leaving 3,650 shares worth $705K. The position accounts for 0.01% of the portfolio, ranked #681.

Geneos Wealth Management first reported a position in TWST in Q4 2020 and has held it in 11 quarters since. 435 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

  • Geneos Wealth Management held 3,650 shares of Twist Bioscience worth $705K as of Q3 2026.
  • Geneos Wealth Management sold 1,650 Twist Bioscience shares in Q3 2026, an estimated $204K.
  • Twist Bioscience made up 0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #681 holding.
  • Geneos Wealth Management first reported a position in Twist Bioscience in Q4 2020 and has held it in 11 quarters since.
  • 435 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.